216 related articles for article (PubMed ID: 1935584)
1. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
[No Abstract] [Full Text] [Related]
2. Criteria for use of colfosceril (Exosurf) in neonates.
Bhatt-Mehta V; Schumacher RE
Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
[No Abstract] [Full Text] [Related]
3. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
4. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
Wyble L; Santeiro ML
Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
[No Abstract] [Full Text] [Related]
5. Comparing surfactant products.
Prevost RR
Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
[No Abstract] [Full Text] [Related]
6. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
[TBL] [Abstract][Full Text] [Related]
7. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
[No Abstract] [Full Text] [Related]
8. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Sanghvi KP; Merchant RH
Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
[No Abstract] [Full Text] [Related]
9. Exogenous surfactant use in neonates.
Ishisaka DY
Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
[TBL] [Abstract][Full Text] [Related]
10. Surfactant respiratory therapy using Surfaxin/sinapultide.
Lal MK; Sinha SK
Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
[TBL] [Abstract][Full Text] [Related]
11. Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
Tooley WH; Clements JA; Muramatsu K; Brown CL; Schlueter MA
Am Rev Respir Dis; 1987 Sep; 136(3):651-6. PubMed ID: 3307569
[TBL] [Abstract][Full Text] [Related]
12. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
Galan HL; Kuehl TJ
Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
[TBL] [Abstract][Full Text] [Related]
13. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Robertson B; Sangstad OD
Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
[No Abstract] [Full Text] [Related]
14. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
15. Surfactant replacement therapy: issues related to currently available preparations.
Bose G
Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367
[No Abstract] [Full Text] [Related]
16. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
17. OSIRIS trial.
Tarnow-Mordi W
Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
[No Abstract] [Full Text] [Related]
18. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
19. [Use of Exosurf Neonatal, a synthetic surfactant, in the treatment of respiratory distress syndrome in the newborn].
Mikhel'sonVA ; Grebennikov VA; Belaĭ VA; Everstova TN
Anesteziol Reanimatol; 1995; (1):4-7. PubMed ID: 7605034
[TBL] [Abstract][Full Text] [Related]
20. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
